Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: pooled data from three large randomised clinical trials. (30th August 2019) - Bissonnette, R.; Fernández‐Peñas, P.; Puig, L.; Mendelsohn, A.M.; Rozzo, S.J.; Menter, A.